NK cell responses to Plasmodium infection and control of intrahepatic parasite development

Journal of Immunology

Volumn 177, Issue 2, 2006, Pages 1229-1239

  Roland, Jacques ^a,c   Soulard, Valérie ^a   Sellier, Christèle ^a   Drapier, Anne Marie ^a   Di Santo, James P ^b   Cazenave, Pierre André ^a   Pied, Sylviane ^a  

^a CNRS   (France)

^b INSERM   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LYSINE; RAG2 PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL COUNT; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; FEMALE; GENE EXPRESSION; HOST RESISTANCE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INFECTION RESISTANCE; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT MOUSE; LIVER CELL; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PARASITE DEVELOPMENT; PHENOTYPE; PLASMODIUM; PLASMODIUM YOELII; PRIMARY INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTOZOAL INFECTION; SPLEEN CELL; SPOROZOITE; SURVIVAL RATE;

EID: 33745816382     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.2.1229     Document Type: Article

References (64)

1. von der Weid, T., N. Honarvar, and J. Langhorne. 1996. Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection. J. Immunol. 156:2510-2516.
2. Good, M. F., and D. L. Doolan. 1999. Immune effector mechanisms in malaria. Curr. Opin. Immunol. 11: 412-419.
3. Hoffman, S. L., and E. D. Franke. 1994. Inducing protective immune responses against the sporozoite and liver stages of Plasmodium. Immunol. Lett. 41: 89-94.
4. Krzych, U., R. Schwenk, M. Guebre-Xabier, P. Sun, D. Palmer, K. White, and I. Chalom. 2000. The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites. Immunol. Rev. 174: 123-134.
5. Oliveira-Ferreira, J., and C. Daniel-Ribeiro. 2001. Protective CD8+ T cell responses against the pre-erythrocytic stages of malaria parasites: an overview. Mem. Inst. Oswaldo. Cruz. 96: 221-227.
6. + T cell clones against Plasmodium yoelii liver stages. J. Immunol. 150: 1471-1478.
7. + T cell and antibody response during a primary Plasmodium chabaudi chabaudi infection in mice. Parasite Immunol. 24: 131-140.
8. Choudhury, H. R., N. A. Sheikh, G. J. Bancroft, D. R. Katz, and J. B. De Souza. 2000. Early nonspecific immune responses and immunity to blood-stage nonlethal Plasmodium yoelii malaria. Infect. Immun. 68: 6127-6132.
9. + TCR αβ intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro. J. Immunol. 164: 1463-1469.
10. Schmieg, J., G. Gonzalez-Aseguinolaza, and M. Tsuji. 2003. The role of natural killer T cells and other T cell subsets against infection by the pre-erythrocytic stages of malaria parasites. Microbes Infect. 5: 499-506.
11. Gonzalez-Aseguinolaza, G., C. de Oliveira, M. Tomaska, S. Hong, O. Bruna-Romero, T. Nakayama, M. Taniguchi, A. Bendelac, L. Van Kaer, Y. Koezuka, and M. Tsuji. 2000. α-Galactosylceramide-activated Vα 14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA 97: 8461-8466.
12. Seixas, E., C. Cross, S. Quin, and J. Langhorne. 2001. Direct activation of dendritic cells by the malaria parasite, Plasmodium chabaudi chabaudi. Eur. J. Immunol. 31: 2970-2978.
13. Serghides, L., T. G. Smith, S. N. Patel, and K. C. Kain. 2003. CD36 and malaria: friends or foes? Trends Parasitol. 19: 461-469.
14. + T cells in the Plasmodium yoelii model. J. Immunol. 163: 884-892.
15. Mohan, K., P. Moulin, and M. M. Stevenson. 1997. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection. J. Immunol. 159: 4990-4998.
16. Nussenzweig, R. S., J. Vanderberg, H. Most, and C. Orton. 1967. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 216: 160-162.
17. Stevenson, M. M., and E. M. Riley. 2004. Innate immunity to malaria. Nat. Rev. Immunol. 4: 169-180.
18. Korbel, D. S., O. C. Finney, and E. M. Riley. 2004. Natural killer cells and innate immunity to protozoan pathogens. Int. J. Parasitol. 34: 1517-1528.
19. Radaev, S., and P. D. Sun. 2003. Structure and function of natural killer cell surface receptors. Annu. Rev. Biophys. Biomol. Struct. 32: 93-114. Epub 2002 Dec 2002.
20. Karlhofer, F. M., R. K. Ribaudo, and W. M. Yokoyama. 1992. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358: 66-70.
21. Yokoyama, W. M. 1995. Natural killer cell receptors specific for major histocompatibility complex class I molecules. Proc. Natl. Acad. Sci. USA 92: 3081-3085.
22. Vance, R. E., J. R. Kraft, J. D. Altman, P. E. Jensen, and D. H. Raulet. 1998. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188: 1841-1848.
23. Anderson, S. K., J. R. Ortaldo, and D. W. McVicar. 2001. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol. Rev. 181: 79-89.
24. Ojo-Amaize, E. A., J. Vilcek, A. H. Cochrane, and R. S. Nussenzweig. 1984. Plasmodium berghei sporozoites are mitogenic for murine T cells, induce interferon, and activate natural killer cells. J. Immunol. 133: 1005-1009.
25. De Souza, J. B., K. H. Williamson, T. Otani, and J. H. Playfair. 1997. Early γ interferon responses in lethal and nonlethal murine blood-stage malaria. Infect. Immun. 65: 1593-1598.
26. Artavanis-Tsakonas, K., and E. M. Riley. 2002. Innate immune response to malaria: rapid induction of IFN-γ from human NK cells by live Plasmodium falciparum-infected erythrocytes. J. Immunol. 169: 2956-2963.
27. Kitaguchi, T., M. Nagoya, T. Amano, M. Suzuki, and M. Minami. 1996. Analysis of roles of natural killer cells in defense against Plasmodium chabaudi in mice. Parasitol. Res. 82: 352-357.
28. Ting, C. C., J. A. Bluestone, M. E. Hargrove, and N. N. Loh. 1986. Expression and function of asialo GM1 in alloreactive cytotoxic T lymphocytes. J. Immunol. 137: 2100-2106.
29. + cells and murine cytomegalovirus infection: what happens in situ? J. Immunol. 166: 1796-1802.
30. + T cells. J. Immunol. 164: 2009-2015.
31. Di Santo, J. P., R. Kuhn, and W. Muller. 1995. Common cytokine receptor γ chain (γ c)-dependent cytokines: understanding in vivo functions by gene targeting. Immunol. Rev. 148: 19-34.
32. Colucci, F., C. Soudais, E. Rosmaraki, L. Vanes, V. L. Tybulewicz, and J. P. Di Santo. 1999. Dissecting NK cell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation. J. Immunol. 162: 2761-2765.
33. Roland, J., and P. A. Cazenave. 1992. Ly-49 antigen defines an αβ TCR population in i-IEL with an extrathymic maturation. Int. Immunol. 4: 699-706.
34. Mazier, D., S. Mellouk, R. L. Beaudoin, B. Texier, P. Druilhe, W. Hockmeyer, J. Trosper, C. Paul, Y. Charoenvit, J. Young, et al. 1986. Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro. Science 231: 156-159.
35. Orange, J. S., and C. A. Biron. 1996. Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156: 4746-4756.
36. Lanier, L., D. Buck, L. Rhodes, A. Ding, E. Evans, C. Barney, and J. Phillips. 1988. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J. Exp. Med. 167: 1572-1585.
37. Testi, R., J. H. Phillips, and L. L. Lanier. 1989. T cell activation via Leu-23 (CD69). J. Immunol. 143: 1123-1128.
38. Tough, D. F., S. Sun, and J. Sprent. 1997. T cell stimulation in vivo by lipopolysaccharide (LPS). J. Exp. Med. 185: 2089-2094.
39. Held, W., and B. Kunz. 1998. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire. Eur. J. Immunol. 28: 2407-2416.
40. Mavoungou, E., A. J. Luty, and P. G. Kremsner. 2003. Natural killer (NK) cell-mediated cytolysis of Plasmodium falciparum-infected human red blood cells in vitro. Eur. Cytokine Netw. 14: 134-142.
41. Artavanis-Tsakonas, K., K. Eleme, K. L. McQueen, N. W. Cheng, P. Parham, D. M. Davis, and E. M. Riley. 2003. Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes. J. Immunol. 171: 5396-5405.
42. Yoneto, T., T. Yoshimoto, C. R. Wang, Y. Takahama, M. Tsuji, S. Waki, and H. Nariuchi. 1999. γ Interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical. Infect. Immun. 67: 2349-2356.
43. Doolan, D. L., and S. L. Hoffman. 2000. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165: 1453-1462.
44. Solomon, J. B., M. G. Forbes, and G. R. Solomon. 1985. A possible role for natural killer cells in providing protection against Plasmodium berghei in early stages of infection. Immunol. Lett. 9: 349-352.
45. Saeftel, M., A. Krueger, S. Arriens, V. Heussler, P. Racz, B. Fleischer, F. Brombacher, and A. Hoerauf. 2004. Mice deficient in interleukin-4 (IL-4) or IL-4 receptor a have higher resistance to sporozoite infection with Plasmodium berghei (ANKA) than do naive wild-type mice. Infect. Immun. 72: 322-331.
46. Biron, C. A., H. A. Young, and M. T. Kasaian. 1990. Interleukin 2-induced proliferation of murine natural killer cells in vivo. J. Exp. Med. 171: 173-188.
47. Robbins, S. H., M. S. Tessmer, T. Mikayama, and L. Brossay. 2004. Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection. J. Immunol. 173: 259-266.
48. Orago, A. S., and C. A. Facer. 1991. Cytotoxicity of human natural killer (NK) cell subsets for Plasmodium falciparum erythrocytic schizonts: stimulation by cytokines and inhibition by neomycin. Clin. Exp. Immunol. 86: 22-29.
49. Raulet, D. H., R. E. Vance, and C. W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19: 291-330.
50. Kim, S., K. Iizuka, H. S. Kang, A. Dokun, A. R. French, S. Greco, and W. M. Yokoyama. 2002. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3: 523-528.
51. Fraser, K. P., F. Gays, J. H. Robinson, K. van Beneden, G. Leclercq, R. E. Vance, D. H. Raulet, and C. G. Brooks. 2002. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2. Eur. J. Immunol. 32: 868-878.
52. Gays, F., K. Martin, R. Kenefeck, J. G. Aust, and C. G. Brooks. 2005. Multiple cytokines regulate the NK gene complex-encoded receptor repertoire of mature NK cells and T cells. J. Immunol. 175: 2938-2947.
53. Daniels, K. A., G. Devora, W. C. Lai, C. L. O'Donnell, M. Bennett, and R. M. Welsh. 2001. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194: 29-44.
54. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
55. Smith, H. R., J. W. Heusel, I. K. Mehta, S. Kim, B. G. Dorner, O. V. Naidenko, K. Iizuka, H. Furukawa, D. L. Beckman, J. T. Pingel, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99: 8826-8831.
56. Stevenson, M., M. Tam, S. Wolf, and A. Sher. 1995. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155: 2545-2556.
57. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182: 1045-1056.
58. Ferreira, A., L. Schofield, V. Enea, H. Schellekens, P. van der Meide, W. E. Collins, R. S. Nussenzweig, and V. Nussenzweig. 1986. Inhibition of development of exoerythrocytic forms of malaria by γ-interferon. Science 232: 881-884.
59. Mellouk, S., R. K. Maheshwari, A. Rhodes-Feuillette, R. L. Beaudoin, N. Berbiguier, H. Matile, F. Miltgen, I. Landau, S. Pied, J. P. Chigot, et al. 1987. Inhibitory activity of interferons and interleukin 1 on the development of Plasmodium falciparum in human hepatocyte cultures. J. Immunol. 139: 4192-4195.
60. Nguyen, K. B., T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X.-q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron. 2002. Coordinated and distinct roles for IFN-αβ, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169: 4279-4287.
61. Vyas, Y. M., H. Maniar, and B. Dupont. 2002. Cutting edge: differential segregation of the SRC homology 2-containing protein tyrosine phosphatase-1 within the early NK cell immune synapse distinguishes noncytolytic from cytolytic interactions. J. Immunol. 168: 3150-3154.
62. Orange, J. S., K. E. Harris, M. M. Andzelm, M. M. Valter, R. S. Geha, and J. L. Strominger. 2003. The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proc. Natl. Acad. Sci. USA 100: 14151-14156. Epub 12003 Nov 14111.
63. Pien, G. C., and C. A. Biron. 2000. Compartmental differences in NK cell responsiveness to IL-12 during lymphocytic choriomeningitis virus infection. J. Immunol. 164: 994-1001.
64. Tay, C. H., and R. M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71: 267-275.